Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 10, Pages e110611
Publisher
Public Library of Science (PLoS)
Online
2014-10-21
DOI
10.1371/journal.pone.0110611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell-penetrating Peptide-based Intelligent Liposomal Systems for Enhanced Drug Delivery
- (2014) Huile Gao et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
- (2014) Yarong Liu et al. MOLECULAR PHARMACEUTICS
- Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs
- (2013) Kye-Il Joo et al. BIOMATERIALS
- Selective Tumor Cell Targeting by the Disaccharide Moiety of Bleomycin
- (2013) Zhiqiang Yu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
- (2011) Hai Wang et al. BIOMATERIALS
- P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance
- (2011) Anne Lespine et al. International Journal for Parasitology-Drugs and Drug Resistance
- Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer
- (2010) Yunching Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endocytosis of nanomedicines
- (2010) Gaurav Sahay et al. JOURNAL OF CONTROLLED RELEASE
- Acute and chronic in vivo therapeutic resistance
- (2009) Beverly A. Teicher BIOCHEMICAL PHARMACOLOGY
- Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma
- (2009) Fabio Calabrò et al. CANCER
- Nanocarriers’ entry into the cell: relevance to drug delivery
- (2009) Hervé Hillaireau et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- ABCG2: A perspective
- (2008) Robert W. Robey et al. ADVANCED DRUG DELIVERY REVIEWS
- Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
- (2008) B. R.J. H. Bird et al. CLINICAL CANCER RESEARCH
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- The Hill equation: a review of its capabilities in pharmacological modelling
- (2008) Sylvain Goutelle et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
- Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
- (2008) Paul D. Dobson et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging Agents in the Treatment of Anthracycline- and Taxane-Refractory Metastatic Breast Cancer
- (2008) Windy Dean-Colomb et al. SEMINARS IN ONCOLOGY
- Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
- (2007) Michele De Laurentiis et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now